Results 131 to 140 of about 64,110 (314)

Availability, use, efficacy and safety of bevacizumab in European hereditary haemorrhagic telangiectasia centres

British Journal of Clinical Pharmacology, Volume 92, Issue 2, Page 535-544, February 2026.
Introduction Bevacizumab, a vascular endothelial growth factor inhibitor, is used off‐label for treatment of severe anaemia related to epistaxis, gastrointestinal bleeding and/or severe hepatic arteriovenous malformations (HAVM) and right‐sided cardiac failure in patients with hereditary haemorrhagic telangiectasia (HHT).
Pernille D. Haahr, Anette D. Kjeldsen, Annette D. Fialla, Anne‐Emmanuelle Fargeton, Alexandre Guilhem, Elisabetta Buscarini, Freya Droege, Guido Manfredi, Hans‐Jurgen Mager, Jean‐Christophe Saurin, Jens Kjeldsen, Josefien Hessels, Marco C. Post, Robert Mandic, Sanne Boerman, Stefan Kasper‐Virchow, Sören Möller, Urban Geisthoff, Sophie Dupuis‐Girod   +18 more
wiley   +1 more source

Portal vein thrombosis as extraintestinal complications of Crohn’s disease: a case report and review of literature

Journal of Medical Case Reports
Introduction Thrombotic events are more than twice as common in inflammatory bowel disease patients as in the general population. We report an interesting and rare case of portal vein thrombosis as a venous thromboembolic event in the context of ...
Marouf Alhalabi, Duaa Nasri, Widad Aji
doaj   +1 more source

Risk factors associated with portal vein thrombosis in liver cirrhosis: A case-control study [PDF]

, 2019
M. Yu. Nadinskaia, Kh. B. Kodzoeva, K. A. Ulyanova, S. I. Rogacheva, А. С. Волкова, Artem S. Dekhanov, Daria Strelkova, В. Т. Ивашкин   +7 more
openalex   +1 more source

Thrombosis of Portal Vein [PDF]

, 2022
L Siddhartha, Saba Ruksaar, Hala Fatima
openalex   +1 more source

Hepatic Arterial Buffer Response: Pathologic Evidence in Non-Cirrhotic Human Liver with Portal Vein Thrombosis [PDF]

, 2016
poster abstractHepatic arterial buffer response (HABR) is the ability of the hepatic artery (HA) to compensate for changes in portal flow. Experimentally, occlusion of the portal vein leads to compensatory increase in HA flow with minimal parenchymal ...
Kwo, Paul Y., Mneimneh, Wadad, Nakanishi, Yukihiro, Rush, Natalia, Saxena, Romil, Sun, Hongliu   +5 more
core  

Impact of Prior Treatment History on Recurrence After Complete Response to Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma

Cancer Medicine, Volume 15, Issue 2, February 2026.
ABSTRACT Aim Integration of locoregional treatments (LRTs) with atezolizumab plus bevacizumab (atezo/bev) has improved treatment outcomes, enabling an increasing number of patients with unresectable hepatocellular carcinoma (HCC) to achieve a complete response (CR). A comprehensive analysis of recurrence following CR may provide insights into prognosis.
Tasuku Nakabori, Masaki Kawabata, Kaori Mukai, Hidenari Hongyo, Noboru Maeda, Makiko Urabe, Yugo Kai, Ryoji Takada, Kenji Ikezawa, Hiroshi Wada, Kunihito Gotoh, Kazuyoshi Ohkawa   +11 more
wiley   +1 more source

Portal Vein Thrombosis in Liver Cirrhosis. Part 1: Epidemiology, Pathogenesis, Clinic, Diag-nosis, Impact on Prognosis

Архивъ внутренней медицины
Portal vein thrombosis is the most common thrombotic complication in patients with liver cirrhosis, especially in cases of severe forms. The pathogenesis is multifactorial in nature, it determined by a change in the balance between the coagulation and ...
A. V. Yagoda, P. V. Koroy, L. S. Baisaeva, T. R. Dudov   +3 more
doaj   +1 more source

Mid‐ to long‐term outcomes of capsular management in hip arthroscopy for FAIS: A multilevel meta‐analysis

Knee Surgery, Sports Traumatology, Arthroscopy, Volume 34, Issue 2, Page 666-683, February 2026.
Abstract Purpose To compare mid‐ to long‐term outcomes of the three major capsular management strategies—capsule preserved (CP), capsule repaired (CR) and capsule unrepaired (CU)—following hip arthroscopy (HAS) for femoroacetabular impingement syndrome (FAIS).
Nikolai Ramadanov, Maximilian Voss, Robert Hable, Robert Prill, Roland Becker, Ingo J. Banke   +5 more
wiley   +1 more source

Portal Vein Thrombosis

Samant H, Asafo-Agyei KO, Kimyaghalam A, Garfield K.   +3 more
europepmc   +3 more sources

„Bottoms-up“ portal venous recanalization TIPS (PVR-TIPS) utilizing a re-entry catheter

CVIR Endovascular
Background Three patients with portal hypertension and gastrointestinal bleeding due to non-cirrhotic portal vein thrombosis were treated with portal venous recanalization transjugular intrahepatic portosystemic shunt (PVR-TIPS) via a trans-splenic ...
Alexander Loizides, Martin Freund, Heinz Zoller, Benedikt Schäfer   +3 more
doaj   +1 more source